Cardiovascular disease (CVD) remains the leading global cause of death, with atherosclerosis as the prominent cause of fatal events in coronaries and peripheral arteries.
In this issue of Atherosclerosis, the paper by Karlöf et al. presented novel data that may provide an insight into the way we could identify stable lesions in carotid arteries.
For decades, numerous research groups have worked to identify patients at risk, and more importantly, lesions susceptible to induce infarcts, strokes or acute ischemia in limbs. Circulating biomarkers (proteins, miRNAs, microvesicles, lipids, cells …) can be potent diagnostic tools for a reliable indication for global disease progression [1] [2] [3] [4] , but still fail to identify and locate high risk lesions for preventive surgical interventions. Anatomical and molecular imaging is the most promising approach for surgically preventing acute cardiovascular events. Molecular imaging strategies combining anatomical and functional imaging modalities (MRI, CT, PET/SPECT, ultrasound, fluorescence) are emerging from preclinical studies to target high risk lesions with critical features like heavy inflammation burden, high metabolic rate, or marked protease activity [5] [6] [7] [8] [9] .
Vascular calcification is a strong and independent predictive factor for cardiovascular complications and mortality [10] . It derives from passive and active processes that are at least partly comparable to cartilage and bone mineralization. In coronary arteries, noninvasive imaging of vascular macrocalcification has been used to detect patients at risk for further events (calcium score) [11] . While calcifications can affect plaque stability depending on their size, nature, extend and location within the lesion, clinical data establishing their direct contribution to plaque symptomatology are still scarce.
In their latest study, published in this issue of Atherosclerosis, Karlöf et al. used conventional CT scan to identify patients with light and heavy calcification in carotid arteries. They correlated heavily calcified lesions with molecular features classically associated with stable lesion, supporting the notion that macro-calcification could indeed stabilize the plaque [12] .
The authors selected patients undergoing carotid endarterectomy with different degrees of calcification in carotid lesions, detected by preoperative angiography, and investigated if global gene expression profiles discriminated patients based on their sole calcification burden and symptomatology. Transcriptomic analysis first compared patients with the most calcified lesions to the least calcified plaques (n = 10 each), then between symptomatic and asymptomatic patients (n = 7 each). High calcification score significantly correlated with increased expression of smooth muscle cell (SMC) markers, extracellular matrix (ECM) related genes, and osteogenic factors, and with downregulation of molecules typically associated with macrophage, ECM degradation, chemokines, and osteoclasts. This finding further illustrates that extended calcification in carotid lesions are found in so-called 'stable' phenotype plaques, with relative repressed or low inflammation burden, high SMC/ECM content (fibrotic lesions), and active osteogenic processes. The authors even revealed a panel of 20 genes explaining up to 65% of the variance between groups with proteoglycan 4 (PRG4) as the top regulated gene in heavily calcified plaques. Authors extended most of their transcriptomic findings to patients with intimal and medial calcification using tissue microarrays (TMA).
This work adds new data regarding molecular signatures of atherosclerotic calcification and explore new angles for identifying stable or unstable lesions. However, among the main limitations of this pilot study, authors failed to reach any significant correlation between calcification burden and patient symptomatology, though this link was already established in previous studies [13] [14] [15] .
PRG4 emerged as the most significantly upregulated gene in heavily calcified lesions, but was downregulated in asymptomatic vs. symptomatic patients with high calcification burden.
Its functional role in plaque calcification was not investigated in the present paper, but these preliminary data further suggest the critical role of cartilage and bone-related extracellular matrix (ECM) proteins lesions [16] [17] [18] [19] , in contrast to microcalcifications likely originating from collagen I degradation in inflamed lesions [20] . Additional work remains necessary to further explore this question. As regard to clinical practice and preoperative diagnosis, much larger patient cohorts need to ascertain the impact of macrocalcification on plaque's stability in peripheral arteries, based on plaque imaging (CT) and patients' symptoms.
